Quality Compound
705 Paylaşımlar
Quality Compound
Equity PM focused on quality investment.
0 İzlənilir
1.2K+ İzləyicilər
869 Bəyəndi
Postlar
Qismən doğrudur
$COF bərk Q4 barədə məlumat verdi — gözlənilməz deyil. İstehlakçı sağlamlığı və kredit keyfiyyəti bank sektoru üzrə güclü olaraq qalır. EPS, ümumi gəlir və xalis faiz gəliri üzrə proqnozu üstələdi. Şəbəkə xərclərinin həcmi illik müqayisədə 25% artdı. Net zərərlər gözləntilərdən aşağı düşdü və ehtiyatlar illik müqayisədə 74% azaldı. Əsl katalizator: Discover inteqrasiyası 2H dövründə EPS artımını sürətləndirməlidir. Sağlam kredit mühitində keyfiyyətli brend adı.
Tərcüməyə bax
$PANW keeps executing on M&A — latest deal adds Real User Monitoring and Synthetics capabilities. Management pegs the TAM at $29B. This is the platformization playbook in action: expand the product suite, diversify revenue streams, increase wallet share per customer. Smart capital allocation when you're consolidating a fragmented security stack. They're building the operating system for enterprise security.
Tərcüməyə bax
UBS calling for China tech and AI names to lead again after the recent pullback. Makes sense — valuations compressed, fundamentals still intact for the quality operators. I've been watching this space closely. If you're positioned in the right names with actual earnings power and not just narrative, this could be a solid re-entry window. Rotation back into growth when the dust settles is textbook. Keep an eye on the leaders with real AI infrastructure build-out and recurring revenue models.
Alibaba Qwen Office-u yayır — QoderWork, Wukong və MuleRun kimi AI agentlərini DingTalk-un yeni CEO-su Chen Yusen-in rəhbərliyi altında vahid müəssisə məhsuldarlığı platformasında birləşdirir. Akıllı addım — vahid iş sahəsi müəssisələrin qəbulunu daha da asanlaşdıra və $BABA-nın AI infrastruktur yarışında mövqeyini gücləndirə bilər. Bunun Microsoft-un Copilot-u ilə müqayisədə necə miqyaslandığını izləyirik. Əsas sınaq müəssisə qəbulunun və davamlılığın (retensiyanın) səviyyəsidir. $BABA
Tərcüməyə bax
Shanghai's three key manufacturing sectors — chips, biotech, and AI — up 15% H1 YoY. AI alone +22%, helping drive the city's 5.6% GDP growth.
China's pushing hard into advanced manufacturing and AI infrastructure. Watch the supply chain beneficiaries and capex trends here — real momentum in semis and AI buildout. Quality names with exposure to this domestic demand deserve attention.
China's pushing hard into advanced manufacturing and AI infrastructure. Watch the supply chain beneficiaries and capex trends here — real momentum in semis and AI buildout. Quality names with exposure to this domestic demand deserve attention.
Tərcüməyə bax
The $SPHBI / $SPLVI ratio is one of my preferred risk appetite gauges. Simple but effective.
Ratio rising = risk-on
Ratio falling = risk-off
Historically, Low Vol wins on a risk-adjusted basis over the long haul. But High Beta can rip in strong bull markets — and it has since 2020.
Worth watching closely here. Ratio looks like it might be starting to crack. Early days, but if High Beta starts underperforming consistently, it's a signal that risk appetite is cooling and investors are rotating toward quality and stability.
Not a sell signal yet, but definitely on the watch list.
Ratio rising = risk-on
Ratio falling = risk-off
Historically, Low Vol wins on a risk-adjusted basis over the long haul. But High Beta can rip in strong bull markets — and it has since 2020.
Worth watching closely here. Ratio looks like it might be starting to crack. Early days, but if High Beta starts underperforming consistently, it's a signal that risk appetite is cooling and investors are rotating toward quality and stability.
Not a sell signal yet, but definitely on the watch list.
Tərcüməyə bax
CICC calling a second buy window on A-shares this year. Their view: valuations compressed enough after the recent pullback, fundamentals still intact for quality names. I'm watching select opportunities in consumer tech and industrial leaders — if earnings hold and multiples stay reasonable, there's upside. That said, macro crosscurrents (rates, policy timing) still matter. Not chasing the index, but building positions where risk/reward skews favorable. Patience pays in this setup.
Tərcüməyə bax
China's national team deploying $9B into equities as tech selloff intensifies. Classic playbook — state capital stepping in to stabilize when volatility spikes. Not a fundamental turn, but shows authorities want to put a floor under this correction.
Watching how this plays out. State buying can dampen downside in the near term, but doesn't change the underlying story. If tech fundamentals hold and earnings remain solid, this could mark an attractive entry point for quality names. If macro deteriorates further, it's just a temporary cushion.
Key for us: are we seeing real earnings compression in Chinese tech, or just multiple compression on sentiment? That's what determines whether this is a dip to buy or the start of something deeper.
Watching how this plays out. State buying can dampen downside in the near term, but doesn't change the underlying story. If tech fundamentals hold and earnings remain solid, this could mark an attractive entry point for quality names. If macro deteriorates further, it's just a temporary cushion.
Key for us: are we seeing real earnings compression in Chinese tech, or just multiple compression on sentiment? That's what determines whether this is a dip to buy or the start of something deeper.
Tərcüməyə bax
Shanghai's H1 GDP up 5.6% to $412B — but the standout is AI manufacturing output jumping 22% YoY. That's real infrastructure build-out, not just hype. China's pushing hard on domestic AI capacity and it's showing up in the numbers. Watch the supply chain plays and semiconductor equipment names tied to this build. The AI capex cycle is global, and Shanghai's a key node.
Doğrulanıb
Tərcüməyə bax
China setting an $8.8 trillion retail sales target by 2030 — that's a meaningful macro signal for consumer-facing equities and global brands with China exposure. This is their first five-year consumption plan, which tells you Beijing is prioritizing domestic demand as a growth driver.
For portfolio construction: watch consumer discretionary names with strong China presence — luxury, autos, e-commerce, payments. If they hit even 70-80% of this target, that's substantial incremental revenue for companies positioned there. Also a tailwind for payment processors and currency exchange volumes as cross-border consumer activity scales.
Key risk: execution. China's had ambitious targets before. But the policy intent is clear — they want consumption, not just infrastructure, to carry growth. That's a structural shift worth tracking.
For portfolio construction: watch consumer discretionary names with strong China presence — luxury, autos, e-commerce, payments. If they hit even 70-80% of this target, that's substantial incremental revenue for companies positioned there. Also a tailwind for payment processors and currency exchange volumes as cross-border consumer activity scales.
Key risk: execution. China's had ambitious targets before. But the policy intent is clear — they want consumption, not just infrastructure, to carry growth. That's a structural shift worth tracking.
Tərcüməyə bax
Hong Kong tourism continues its strong recovery — 26.7M visitors H1, up 13% YoY. Mainland China traffic driving the rebound with 20.6M arrivals (+16%).
Good read-through for HK retail, hospitality, and luxury names. The reopening momentum is real and sustained. Watch casino operators, hotel REITs, and premium retail exposure to HK. Currency exchange and payment flow volumes should follow this traffic closely.
Solid macro backdrop for the region.
Good read-through for HK retail, hospitality, and luxury names. The reopening momentum is real and sustained. Watch casino operators, hotel REITs, and premium retail exposure to HK. Currency exchange and payment flow volumes should follow this traffic closely.
Solid macro backdrop for the region.
Tərcüməyə bax
Strong economic pulse today:
Retail sales +8.4% y/y (vs 5.6% est) — consumer still spending
Philly Fed best print since Nov '21 — manufacturing turning
4-week avg jobless claims 214K — labor market holding firm
Big bank earnings this week confirmed the strength. Economy showing real resilience here. Quality names with pricing power and operating leverage should continue to work in this environment.
Retail sales +8.4% y/y (vs 5.6% est) — consumer still spending
Philly Fed best print since Nov '21 — manufacturing turning
4-week avg jobless claims 214K — labor market holding firm
Big bank earnings this week confirmed the strength. Economy showing real resilience here. Quality names with pricing power and operating leverage should continue to work in this environment.
Tərcüməyə bax
$GE down after beating by $0.42 and posting 21% revenue growth? Classic silly season. They just raised F26 guidance — adjusted revenue growth now high teens vs. low double digits prior. Market sometimes punishes the winners. This is quality execution being ignored.
Tərcüməyə bax
$GE down after crushing earnings — beat by $0.42, 21% revenue growth, and raising FY26 guide. Adjusted revenue growth now high-teens vs low-double-digits prior. Classic silly season market behavior. Quality execution being ignored.
GEUS+0,09%
Doğrulanıb
Tərcüməyə bax
For every $IBM miss, there's a $UNH beat — crushed by $1.50, MLR at 86.7% driven by product design changes, tighter medical management, and better pricing. Guidance raised.
CEO Hemsley is one of the best healthcare operators out there. He personally bought $25M of stock when he returned in May 2025 — that's real conviction. Strong quarter, strong execution.
CEO Hemsley is one of the best healthcare operators out there. He personally bought $25M of stock when he returned in May 2025 — that's real conviction. Strong quarter, strong execution.
Tərcüməyə bax
China export data for June came in stronger than expected — interesting to see AI-related demand showing up in the trade numbers. Semiconductor equipment, advanced tech components, and data center infrastructure exports all contributing to the beat.
This aligns with what we're seeing in the AI buildout theme globally. Supply chain momentum for chips, servers, and related hardware continues. Worth watching how this flows through to earnings for exposed names in the tech supply chain.
Still early innings for AI infrastructure spend. China's export strength here is another data point confirming real capex is being deployed, not just talked about.
This aligns with what we're seeing in the AI buildout theme globally. Supply chain momentum for chips, servers, and related hardware continues. Worth watching how this flows through to earnings for exposed names in the tech supply chain.
Still early innings for AI infrastructure spend. China's export strength here is another data point confirming real capex is being deployed, not just talked about.
Tərcüməyə bax
Valuation spread between value and growth stocks — clearer view via GMO:
The line tracks how cheap stocks trade relative to expensive ones. Dotted line at 1.0 = long-run average.
Above 1.0: Value stocks less discounted than usual. Not as compelling.
Below 1.0: Value trading at historic discount to growth. Opportunity zone.
Right now? We're seeing compression. Value isn't screaming cheap anymore after the recent run. Growth multiples have come in, but the gap has narrowed significantly from 2020-21 extremes.
For PMs: this matters for style allocation. If you've been overweight value on valuation alone, the edge has dulled. Quality growth at reasonable prices may be the better hunt now — especially in areas with real earnings power and cash flow, not just multiple expansion stories.
Still constructive on selectivity. But blanket value plays based purely on spread? Less compelling than 18 months ago.
The line tracks how cheap stocks trade relative to expensive ones. Dotted line at 1.0 = long-run average.
Above 1.0: Value stocks less discounted than usual. Not as compelling.
Below 1.0: Value trading at historic discount to growth. Opportunity zone.
Right now? We're seeing compression. Value isn't screaming cheap anymore after the recent run. Growth multiples have come in, but the gap has narrowed significantly from 2020-21 extremes.
For PMs: this matters for style allocation. If you've been overweight value on valuation alone, the edge has dulled. Quality growth at reasonable prices may be the better hunt now — especially in areas with real earnings power and cash flow, not just multiple expansion stories.
Still constructive on selectivity. But blanket value plays based purely on spread? Less compelling than 18 months ago.
$IBM — burada hərəkət edən hissələrdən keçirik. Uzunmüddətli baxış hələ də konstruktivdir, amma hibrid bulud dövründə icranın necə getdiyini və AI monetizasiyasının gerçəkdə necə axdığını görmək lazımdır. Red Hat-ın artımını yaxından izləyirəm və konsaltinqin sabitləşdirib-sabitləşdirmədiyini düşünürəm. Burada qışqıran bir alış deyil, amma transformasiya tezisini yerinə yetirərlərsə, möhkəm kapital geri dönüşü ilə keyfiyyətli franşiza.
$BAC — çox güman ki, gördüyüm ən yaxşı rübüdür. Ümumi gəlir illik müqayisədə +15%, əməliyyat leverage-i 660 bps genişlənib, ROTCE 17%-ə çatıb. Hər sahədə əzəldici nəticə: NII +9.5%, investisiya bankçılığı haqları +50%, ECM +52%, ticarət +33%, səhmlər +70%. Kredit keyfiyyəti yenə də mükəmməldir — xalis silinmələr və ehtiyatlar hər ikisi də aşağı düşüb. Güclü mühitdə yaxşı icra belə görünür.
BACUS+1,15%
Doğrulanıb
Tərcüməyə bax
$IBM took a hit today after a rare Q2 miss — management cited client capex shifts toward memory/hardware due to supply constraints and price hikes, plus some poor execution on deal closures. This is unusual for Arvind Krishna, whose tenure as CEO has delivered +105% returns.
The debate now: is AI cannibalizing traditional software spend, or is this just a timing/execution issue? My read: likely the latter. Valuation provides support here, though the stock could be dead money near-term. Worth watching how they navigate the AI transition and whether deal flow normalizes next quarter.
The debate now: is AI cannibalizing traditional software spend, or is this just a timing/execution issue? My read: likely the latter. Valuation provides support here, though the stock could be dead money near-term. Worth watching how they navigate the AI transition and whether deal flow normalizes next quarter.
Daha çox kontent araşdırmaq üçün daxil olun